Monthly data will track post-surgical pain management treatments with a focus on emerging therapies
March 31, 2015 (NEW YORK) — Guidepoint, a leading global research services firm, today announced the launch of the Post-Surgical Pain Management TRACKER, part of the Guidepoint TRACKER suite of data products tracking usage trends in the medical device and therapeutics markets. The Post-Surgical Pain Management TRACKER delivers monthly access to data including treatment volumes, market share, and adoption rates across three major modalities used to manage the pain associated with joint surgery.
The Post-Surgical Pain Management TRACKER will provide length of stay insights, patient pain score trends, and opioid use trends, along with timely and topical supplementary data within major joint replacement and other surgical settings.
Kenneth Wahl, Vice President, Business Development for Guidepoint TRACKER, said: “Our clients are focused on how market share and adoption rates for emerging pain management therapies will unfold in light of published clinical data, potential FDA approvals for new indications, and varied end market preference for the major categories of treatment targeting post-surgical pain.”
Each month, Guidepoint collects data from an anonymous, same-site panel conducting approximately two percent of the major joint replacement procedures in the U.S. The Post-Surgical Pain Management TRACKER will capture data for products manufactured by companies including Pacira Pharmaceuticals and Halyard Health and will deliver monthly treatment volumes across three major categories:
- Local anesthetics including long-acting infiltration, short-acting infiltration, elastomeric pumps, and other catheter-based systems
- Opioids including oral, intravenous, and patient controlled analgesia (PCA) devices
- Nerve blocks including long and short-acting peripheral, spinal, and epidural
- Subscribers can access monthly data via the Guidepoint TRACKER web portal.
ABOUT GUIDEPOINT TRACKER
Since 2006, Guidepoint TRACKER has equipped institutional investors and manufacturers with monthly volume, market share, and other commercial insights for medical device and biopharmaceutical utilization, as reported by representative, anonymous, same-site panels.
Guidepoint TRACKER data and market models are exclusively available to Guidepoint clients via a web-based platform.
ABOUT GUIDEPOINT
Guidepoint Global, LLC, operating as Guidepoint, is a leading global research services firm that connects business decision-makers and researchers with knowledgeable independent experts across 110 industries. Since 2003, Guidepoint has provided its clients with practical insights, setting up more than 500,000 interactions. Its slate of services, including phone consultations and meetings with Advisors, custom surveys, and proprietary data products, help professionals gain comprehensive understanding of a topic before making major investment and/or business decisions. Guidepoint’s multinational client list includes seven of the top 10 consulting firms, seven of the top 10 hedge funds, and some of the largest private equity firms and Fortune-ranked companies. Guidepoint’s industry-leading compliance platform—overseen by Guidepoint’s General Counsel, a former SEC enforcement attorney—supports appropriate client-to-Advisor interactions through the application of Guidepoint’s own policies and procedures as well as custom, client-specific controls the company implements at clients’ requests. For more information, visit www.guidepointglobal.com.